Beyond Air, Inc. (XAIR)
USD 0.24
(-0.49%)
USD 0.24
(-0.49%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 56.96 Million USD | -17.15% |
| 2023 | 68.74 Million USD | -30.7% |
| 2022 | 99.19 Million USD | 144.78% |
| 2021 | 40.52 Million USD | 47.71% |
| 2020 | 27.43 Million USD | 190.99% |
| 2019 | 9.42 Million USD | 0.78% |
| 2018 | 9.35 Million USD | 3864.01% |
| 2017 | 236 Thousand USD | 3870.39% |
| 2016 | 5944.00 USD | -59.28% |
| 2015 | 14.59 Thousand USD | -92.44% |
| 2014 | 193 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 FY | 56.96 Million USD | -17.15% |
| 2024 Q1 | 73.04 Million USD | 6.25% |
| 2024 Q2 | 58 Million USD | -20.59% |
| 2024 Q3 | 51.91 Million USD | -10.51% |
| 2024 Q4 | 56.96 Million USD | 9.73% |
| 2023 FY | 68.74 Million USD | -30.7% |
| 2023 Q2 | 82.03 Million USD | -10.73% |
| 2023 Q3 | 73.95 Million USD | -9.85% |
| 2023 Q4 | 68.74 Million USD | -7.04% |
| 2023 Q1 | 91.9 Million USD | -7.35% |
| 2022 Q2 | 54.05 Million USD | 22.38% |
| 2022 Q4 | 99.19 Million USD | -0.11% |
| 2022 FY | 99.19 Million USD | 144.78% |
| 2022 Q1 | 44.16 Million USD | 8.99% |
| 2022 Q3 | 99.31 Million USD | 83.72% |
| 2021 Q2 | 24.47 Million USD | -8.94% |
| 2021 Q3 | 24.81 Million USD | 1.41% |
| 2021 Q4 | 40.52 Million USD | 63.29% |
| 2021 FY | 40.52 Million USD | 47.71% |
| 2021 Q1 | 26.87 Million USD | -2.04% |
| 2020 Q2 | 11.14 Million USD | -15.07% |
| 2020 FY | 27.43 Million USD | 190.99% |
| 2020 Q4 | 27.43 Million USD | 63.72% |
| 2020 Q3 | 16.75 Million USD | 50.38% |
| 2020 Q1 | 13.12 Million USD | 39.16% |
| 2019 Q3 | 3.9 Million USD | -25.75% |
| 2019 Q4 | 9.42 Million USD | 141.18% |
| 2019 Q1 | 7.09 Million USD | -24.12% |
| 2019 FY | 9.42 Million USD | 0.78% |
| 2019 Q2 | 5.26 Million USD | -25.83% |
| 2018 Q4 | 9.35 Million USD | 327.36% |
| 2018 Q3 | 2.18 Million USD | -46.33% |
| 2018 FY | 9.35 Million USD | 3864.01% |
| 2018 Q1 | 5.49 Million USD | -25.76% |
| 2018 Q2 | 4.07 Million USD | -25.73% |
| 2017 Q2 | 2967.00 USD | -50.08% |
| 2017 Q4 | 7.39 Million USD | 3034.75% |
| 2017 FY | 236 Thousand USD | 3870.39% |
| 2017 Q1 | 5944.00 USD | 96.82% |
| 2017 Q3 | 236 Thousand USD | 7854.16% |
| 2016 Q3 | 5559.00 USD | 0.0% |
| 2016 Q4 | 3020.00 USD | -45.67% |
| 2016 FY | 5944.00 USD | -59.28% |
| 2016 Q1 | 498 Thousand USD | 0.0% |
| 2016 Q2 | - USD | -100.0% |
| 2015 Q3 | 334 Thousand USD | 0.0% |
| 2015 Q2 | 334 Thousand USD | 0.0% |
| 2015 FY | 14.59 Thousand USD | -92.44% |
| 2015 Q4 | 498 Thousand USD | 49.1% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | 193 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -81.601% |
| BrainsWay Ltd. | 62.97 Million USD | 9.546% |
| Cerus Corporation | 197.74 Million USD | 71.195% |
| Envoy Medical, Inc. | 7.64 Million USD | -645.563% |
| electroCore, Inc. | 16.38 Million USD | -247.599% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -640.523% |
| IceCure Medical Ltd | 16.41 Million USD | -247.112% |
| Inogen, Inc. | 326.19 Million USD | 82.538% |
| OrthoPediatrics Corp. | 449.58 Million USD | 87.33% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -108.878% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -243.573% |
| MaxCyte, Inc. | 268.27 Million USD | 78.768% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -603.455% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1468.346% |
| Orthofix Medical Inc. | 925.31 Million USD | 93.844% |
| PAVmed Inc | 33.11 Million USD | -71.989% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 60.293% |
| RxSight, Inc. | 182.55 Million USD | 68.797% |
| Sight Sciences, Inc. | 166.65 Million USD | 65.82% |
| SI-BONE, Inc. | 230.42 Million USD | 75.28% |
| TELA Bio, Inc. | 78.04 Million USD | 27.018% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 77.388% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -430.857% |
| Acutus Medical, Inc. | 53.96 Million USD | -5.562% |
| Talis Biomedical Corporation | 98.34 Million USD | 42.077% |
| Spectral AI, Inc. | 10.69 Million USD | -432.744% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 73.949% |
| CVRx, Inc. | 115.22 Million USD | 50.567% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 2.898% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -1728.455% |
| Bioventus Inc. | 810.91 Million USD | 92.976% |
| Venus Concept Inc. | 93.65 Million USD | 39.179% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -121.423% |
| LivaNova PLC | 2.42 Billion USD | 97.656% |
| 908 Devices Inc. | 202.98 Million USD | 71.938% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 92.926% |
| Nemaura Medical Inc. | 14.56 Million USD | -291.129% |
| NeuroPace, Inc. | 107.65 Million USD | 47.087% |
| LENSAR, Inc. | 69.58 Million USD | 18.142% |
| Apyx Medical Corporation | 79.24 Million USD | 28.116% |
| Cutera, Inc. | 346.29 Million USD | 83.551% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -35.57% |
| BioSig Technologies, Inc. | 1.79 Million USD | -3068.02% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 78.953% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -33.52% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 98.494% |
| Axonics, Inc. | 719.92 Million USD | 92.088% |
| Outset Medical, Inc. | 313.8 Million USD | 81.848% |
| IRIDEX Corporation | 34.43 Million USD | -65.411% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 85.926% |
| IRadimed Corporation | 92.15 Million USD | 38.191% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -984.145% |
| INVO Bioscience, Inc. | 20.88 Million USD | -172.7% |
| Telesis Bio, Inc. | 70.41 Million USD | 19.102% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 63.037% |
| Varex Imaging Corporation | 1.24 Billion USD | 95.442% |
| Quipt Home Medical Corp. | 247.4 Million USD | 76.977% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -511.826% |
| Pulmonx Corporation | 178.95 Million USD | 68.169% |
| Dynatronics Corporation | 25.94 Million USD | -119.583% |
| Modular Medical, Inc. | 13.8 Million USD | -312.552% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -431.006% |
| Semler Scientific, Inc. | 78.06 Million USD | 27.034% |
| InMode Ltd. | 863.28 Million USD | 93.402% |
| Bruker Corporation | 4.24 Billion USD | 98.66% |
| Cytosorbents Corporation | 53.26 Million USD | -6.948% |
| DexCom, Inc. | 6.26 Billion USD | 99.091% |
| Align Technology, Inc. | 6.08 Billion USD | 99.064% |
| Viveve Medical, Inc. | 25.91 Million USD | -119.816% |
| ZimVie Inc. | 1.2 Billion USD | 95.274% |
| Movano Inc. | 9.42 Million USD | -504.617% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 88.554% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1468.346% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 2.898% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 94.021% |
| Profound Medical Corp. | 43.68 Million USD | -30.386% |
| Insulet Corporation | 2.58 Billion USD | 97.799% |
| enVVeno Medical Corporation | 48.63 Million USD | -17.119% |
| Surmodics, Inc. | 185.73 Million USD | 69.332% |
| iCAD, Inc. | 41.41 Million USD | -37.527% |
| Nuwellis, Inc. | 9.77 Million USD | -483.019% |
| Biotricity, Inc. | 5.94 Million USD | -858.516% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 86.849% |
| Aethlon Medical, Inc. | 8.24 Million USD | -590.773% |
| InspireMD, Inc. | 47.64 Million USD | -19.558% |
| PAVmed Inc. | 33.11 Million USD | -71.989% |
| BIOLASE, Inc. | 35.1 Million USD | -62.277% |
| FONAR Corporation | 214.24 Million USD | 73.413% |
| AxoGen, Inc. | 196.82 Million USD | 71.06% |
| Vivani Medical, Inc. | 45.79 Million USD | -24.377% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 79.761% |
| Inari Medical, Inc. | 674.23 Million USD | 91.552% |
| UFP Technologies, Inc. | 404.13 Million USD | 85.905% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -143.438% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -499.393% |
| Tenon Medical, Inc. | 6.34 Million USD | -797.73% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -505.517% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 45.044% |
| AdaptHealth Corp. | 4.61 Billion USD | 98.767% |
| Sintx Technologies, Inc. | 15.36 Million USD | -270.719% |
| NanoVibronix, Inc. | 6.67 Million USD | -753.476% |
| Quanterix Corporation | 425.01 Million USD | 86.598% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -511.826% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -6.019% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 96.738% |
| TransMedics Group, Inc. | 706.04 Million USD | 91.932% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 9.86% |
| NeuroMetrix, Inc. | 21.42 Million USD | -165.869% |
| Hyperfine, Inc. | 94.19 Million USD | 39.531% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 78.797% |
| Biomerica, Inc. | 9.25 Million USD | -515.528% |
| Bone Biologics Corporation | 3.73 Million USD | -1423.933% |
| AVITA Medical, Inc. | 144.33 Million USD | 60.537% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -1069.983% |
| Silk Road Medical, Inc | 265.3 Million USD | 78.53% |